Physician

Ciara Marie Kelly, MB BCH BAO

According to 2025 Medicare claims, Ciara Kelly, MB BCH BAO (NPI: 1144696485) practices medical oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is MEMORIAL SOLID TUMOR GROUP (NPI: 1699746172; TIN: 133278578) and primary practice location at 10022-5243.

Kelly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 168 traditional Medicare patients, billed 714 HCPCS/CPT codes, and received $72,003 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 534 prescription claims across 86 beneficiaries totaling $2,235,478 in drug costs, led by Qinlock (Ripretinib). DME data shows 37 claims. Open Payments data shows 26 records totaling $698,573. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $13,359 and ending at $72,003. Concurrently, Part D prescription costs have risen steadily, from $611 to $2,235,478. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	73	160	$13,359
2018	157	571	$44,190
2019	118	375	$26,594
2020	128	688	$43,774
2021	64	158	$12,554
2022	151	583	$50,774
2023	143	527	$49,021
2024	168	714	$72,003

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	11	$611
2017	33	100	$419,878
2018	71	309	$626,141
2019	44	171	$293,804
2020	66	440	$439,046
2021	34	102	$248,976
2022	42	198	$584,906
2023	60	357	$819,039
2024	86	534	$2,235,478

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	22	$243
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	37	$2,204

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	35	35	$160
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	90	237	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	102	293	$88
99442	Telephone medical discussion with physician, 11-20 minutes	19	20	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	50	78	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Qinlock	Ripretinib	14	420	$1,117,093
Imatinib Mesylate	Imatinib Mesylate	109	3,870	$327,166
Cabometyx	Cabozantinib S-Malate	13	390	$302,689
Sunitinib Malate	Sunitinib Malate	16	470	$109,480
Mounjaro	Tirzepatide	16	930	$33,916

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	12	$1,324
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	13	$613
A4394	Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce	N	N/R	12	$267

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$17,985	Deciphera Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	12	$680,588	Servier BioInnovation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ciara Marie Kelly, MB BCH BAO?

Tedicare shows public-source Medicare data for Ciara Marie Kelly, MB BCH BAO (NPI 1144696485), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ciara Marie Kelly, MB BCH BAO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ciara Marie Kelly, MB BCH BAO?

Ciara Marie Kelly, MB BCH BAO is linked to MEMORIAL SOLID TUMOR GROUP (billing NPI 1699746172) in the available physician profile data.

Does Ciara Marie Kelly, MB BCH BAO have Open Payments data?

Ciara Marie Kelly, MB BCH BAO has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.